about
Alector Inc is a clinical-stage biotechnology company focused on developing therapies for neurodegenerative diseases. The company advances a pipeline of product candidates including Nivisnebart (AL101/GSK4527226) for Alzheimer's disease, AL137 for Al...
Read More
1.93
0.02
(1.05%)
1.2M
XNAS Volume
XNAS 21 Sep, 2026 5:30 PM (EDT)
Not Eligible
Expensive Valuation
Technically Neutral
Alector Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..